Medical costs of cancer attributable to work in the Basque Country (Spain) in 2008

Gómez, Montserrat García; López, Rosario Castañeda; Urbanos-Garrido, Rosa M.; Menduiña, Patricia López; Markowitz, Steven

doi:10.1016/j.gaceta.2013.01.002

Cited by 6 publications

(9 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As such, occupational BC remains an important public health issue. 27,28 Comparisons within each class over time revealed either no change in risk or insufficient studies (number, size, or distribution) to make meaningful comparisons. Exceptions included drivers, whose risk seems to be declining.…”

Section: Discussionmentioning

confidence: 99%

Contemporary Occupational Carcinogen Exposure and Bladder Cancer

et al. 2015

View full text Add to dashboard Cite

IMPORTANCEBladder cancer (BC) is a common disease. Despite manufacturing and legislative changes to workplace hygiene, many BCs still arise through occupational carcinogen exposure.OBJECTIVE To profile contemporary risks of occupational BC.DATA SOURCES A systematic review using PubMed, Medline, Embase, and Web of Science was performed in October 2012 (initial review) and May 2014 (final review) and was updated in June 2015.STUDY SELECTION We identified 263 eligible articles. We excluded reports in which BC or occupation were not the main focus, and those with insufficient case, risk, or confidence interval data. We selected the most recent data from populations with multiple reports.DATA EXTRACTION AND SYNTHESIS Reports were selected by 2 of us independently. We combined odds ratios and risk ratios (RRs) to provide pooled RRs, using maximally adjusted RRs in a random effects model. Heterogeneity and publication bias were assessed using I 2 and Begg and Egger tests. Risk estimates were annotated by occupational class using Nordisk Yrkesklassificering, or Nordic Occupational Classification, and International Standard Classifications of Occupations (NYK and ISCO-1958) Codes. MAIN OUTCOMES AND MEASURESOccupations were profiled by BC incidence and mortality risk over time. After data collection, we detected a sex difference in these profiles and recorded this as a secondary outcome.RESULTS Meta-analysis revealed increased BC incidence in 42 of 61 occupational classes and increased BC-specific mortality in 16 of 40 occupational classes. Reduced incidence and mortality were seen in 6 of 61 and 2 of 40 classes, respectively. Risk varied with sex and was greatest in men (standardized incidence ratio, 1.03 [95% CI, 1.02-1.03]; P < .001]). From the 1960s to the 1980s, there was a steady decline in standarized incidence ratio (SIR) for both sexes. This trend reversed from the 1980s, as in the decade 2000 to 2010 the SIR increased to 1.13 (95% CI, 1.07-1.19) for men and 1.27 (95% CI, 1.12-1.43) for women. In contrast, mortality risk declined for both sexes from the 1960s to the 1990s. The overall risk of BC mortality was also greater for men (standardized mortality ratio [SMR], 1.32 [95% CI, 1.18-1.48]) than for women (SMR, 1.14 [95% CI,). Limitations include possible publication bias, that reports stratify workers mostly by job title not task, that not all studies adjusted for smoking, and that the population was mostly derived from Western nations.CONCLUSIONS AND RELEVANCE The profile of contemporary occupations with increased BC risk is broad and differs for incidence and mortality. Currently the incidence seems to be increasing, and this increase is occurring faster in women than men. Improved detection mechanisms and screening are possible reasons for this. Workers with aromatic amine exposure have the highest incidence, while those exposed to polycyclic aromatic hydrocarbons and heavy metals have the greatest mortality.

show abstract

Section: Discussionmentioning

confidence: 99%

Contemporary Occupational Carcinogen Exposure and Bladder Cancer

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Gomez et al examined direct medical cost for job-related cancers in Spain in 2008, 20 finding that total annual hospital costs for males with mesothelioma were €498,110, and total hospital costs for females were €66,766. Cost per hospitalization, however, was similar between males and females (€6,731 vs €6,676).…”

Section: Resultsmentioning

confidence: 99%

“…The systematic literature review of PubMed returned 167 hits for the search terms “mesothelioma AND cost,” with five studies meeting our inclusion criteria. 17–21 The review of the ISPOR scientific presentation database returned 11 matches for the search term “mesothelioma” of which two were applicable. 22,23 The review of the IPA database returned six matches for the search terms “mesothelioma AND cost,” but none were applicable.…”

Section: Resultsmentioning

confidence: 99%

“…The average annual per patient cost burden of mesothelioma in France was estimated at €33,422 (approximately US US$40,899 in 2010 dollars). 20 These reports suggest that the cost of care for mesothelioma is comparable to costs of care for other respiratory cancers. For example, annual costs of initial care for lung cancer have been estimated at US$72,639 among non-senior adults (2010 dollars).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Costs of medical care for mesothelioma

2019

View full text Add to dashboard Cite

Malignant mesothelioma is a rare and devastating form of cancer with an increasing economic burden. We sought to describe the direct cost burden of mesothelioma to the US health system. A systematic literature review was performed to locate published estimates of the medical cost of mesothelioma. In addition, we performed an analysis of hospital discharge data from the National Inpatient Sample, Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality. We also reviewed publicly available legal settlements. We found that published estimates of the cost of medical care for mesothelioma are sparse, and differ with respect to nation, timeframe, and types of cost included. For the year 2014 in the United States, we estimated a mean cost per mesothelioma hospitalization of US$24,124 (95% confidence interval: US$20,819–US$28,983) and a total cost for hospital care of US$44,214,835. In conclusion, we found that reports describing the direct medical cost of care for mesothelioma in the United States are lacking, yet the per-patient cost of care is substantial, as evidenced by analyses of inpatient care and legal settlements.

show abstract

“…Estimations of the monetized costs of cancer vary across regions, years, and the specific types of costs included in the calculation. For example, work attributable cancers are estimated to have cost the Spanish Basque health system close to €10 million in 2008 [ 15 ]. Costs for all of France in 2010 are estimated between €917 million and €2.18 billion, including direct and indirect social costs [ 16 ].…”

Section: Literaturementioning

confidence: 99%

Costs of productivity loss due to occupational cancer in Canada: estimation using claims data from Workers’ Compensation Boards

Wranik

Muir

2017

Health Econ Rev

View full text Add to dashboard Cite

IntroductionCancer is a leading cause of illness globally, yet our understanding of the financial implications of cancer caused by working conditions and environments is limited. The goal of this study is to estimate the costs of productivity losses due to occupational cancer in Canada, and to evaluate the factors associated with these costs.MethodsTwo sources of data are used: (i) Individual level administrative claims data from the Workers Compensation Board of Nova Scotia; and (ii) provincial aggregated cancer claims statistics from the Association of Workers Compensation Boards of Canada. Benefits paid to claimants are based on actuarial estimates of wage-loss, but do not include medical costs that are covered by the Canadian publicly funded healthcare system. Regional claims level data are used to estimate the total and average (per claim) cost of occupational cancer to the insurance system, and to assess which characteristics of the claim/claimant influence costs. Cost estimates from one region are weighted using regional multipliers to adjust for system differences between regions, and extrapolated to estimate national costs of occupational cancer.Results/DiscussionWe estimate that the total cost of occupational cancer to the Workers’ Compensation system in Canada between 1996 and 2013 was $1.2 billion. The average annual cost was $68 million. The cancer being identified as asbestos related were significantly positively associated with costs, whereas the age of the claimant was significantly negatively associated with costs. The industry type/region, injury type or part of body affected by cancer were not significant cost determinants.ConclusionGiven the severity of the cancer burden, it is important to understand the financial implications of the disease on workers. Our study shows that productivity losses associated with cancer in the workplace are not negligible, particularly for workers exposed to asbestos.Electronic supplementary materialThe online version of this article (doi:10.1186/s13561-017-0145-7) contains supplementary material, which is available to authorized users.

show abstract

Medical costs of cancer attributable to work in the Basque Country (Spain) in 2008

Cited by 6 publications

References 22 publications

Contemporary Occupational Carcinogen Exposure and Bladder Cancer

Contemporary Occupational Carcinogen Exposure and Bladder Cancer

Costs of medical care for mesothelioma

Costs of productivity loss due to occupational cancer in Canada: estimation using claims data from Workers’ Compensation Boards

Contact Info

Product

Resources

About